These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26327459)

  • 1. Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in polycystic ovary syndrome.
    Bui HN; Sluss PM; Hayes FJ; Blincko S; Knol DL; Blankenstein MA; Heijboer AC
    Clin Chim Acta; 2015 Oct; 450():227-32. PubMed ID: 26327459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.
    Handelsman DJ; Teede HJ; Desai R; Norman RJ; Moran LJ
    Hum Reprod; 2017 Feb; 32(2):418-422. PubMed ID: 27999117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
    Barth JH; Field HP; Yasmin E; Balen AH
    Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort.
    Glintborg D; Jensen RC; Bentsen K; Schmedes AV; Brandslund I; Kyhl HB; Bilenberg N; Andersen MS
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3819-3827. PubMed ID: 30060213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND; Sthaneshwar P; Razali N
    Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.
    Yasmin E; Balen AH; Barth JH
    Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
    Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
    J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
    Chanukvadze D; Kristesashvili J
    Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome.
    Yang Y; Ouyang N; Ye Y; Hu Q; Du T; Di N; Xu W; Azziz R; Yang D; Zhao X
    Reprod Biomed Online; 2020 Oct; 41(4):734-742. PubMed ID: 32912651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study.
    Pinola P; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Ruokonen A; Puukka K; Tapanainen JS; Morin-Papunen LC
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3400-7. PubMed ID: 26192874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria.
    Salameh WA; Redor-Goldman MM; Clarke NJ; Mathur R; Azziz R; Reitz RE
    Fertil Steril; 2014 Apr; 101(4):1135-1141.e2. PubMed ID: 24534279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia.
    Cho LW; Kilpatrick ES; Jayagopal V; Diver MJ; Atkin SL
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):390-4. PubMed ID: 17888022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Three Androgen Indexes (FAI, FT, and TT) on Clinical, Biochemical, and Fertility Outcomes in Women with Polycystic Ovary Syndrome.
    Zhang D; Gao J; Liu X; Qin H; Wu X
    Reprod Sci; 2021 Mar; 28(3):775-784. PubMed ID: 32989632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of total testosterone and free androgen index measured by LC-MS/MS for PCOS and insulin resistance.
    Xu S; Liu Y; Xue K; Liu X; Jia G; Zeng Y; Chen Y
    J Clin Lab Anal; 2022 Nov; 36(11):e24739. PubMed ID: 36258308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.
    Pall ME; Lao MC; Patel SS; Lee ML; Ghods DE; Chandler DW; Friedman TC
    Horm Metab Res; 2008 Nov; 40(11):813-8. PubMed ID: 18819057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome.
    Caanen MR; Kuijper EA; Hompes PG; Kushnir MM; Rockwood AL; Meikle WA; Homburg R; Lambalk CB
    Eur J Endocrinol; 2016 Jan; 174(1):25-32. PubMed ID: 26586837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome.
    Jedel E; Gustafson D; Waern M; Sverrisdottir YB; Landén M; Janson PO; Labrie F; Ohlsson C; Stener-Victorin E
    Psychoneuroendocrinology; 2011 Nov; 36(10):1470-9. PubMed ID: 21549510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.